Braves Make Surprising Decision On Chris Sale's Future

Braves secure Chris Sale's future with a lucrative extension, staking a bold claim on their star pitcher's skills despite past injury setbacks.

The Atlanta Braves have made headlines with two major announcements that have fans buzzing. First, they've launched their own TV and streaming network, a bold move that underscores their commitment to expanding their brand and connecting with fans in new ways. But perhaps even more exciting for Braves supporters is the extension of their star pitcher, Chris Sale.

Sale, who was in the final year of his previous contract, is now secured for the 2027 season with a salary bump to $27 million. The deal also includes a club option for 2028 at $30 million, giving the Braves flexibility in the face of future labor negotiations.

Despite battling injuries last season, Sale's performance on the mound was nothing short of spectacular. In just 20 starts, he posted impressive numbers: a 61 ERA-, 67 FIP-, and 73 xFIP-, translating to a 3.6 fWAR over 125 2/3 innings. These stats highlight his dominance and resilience, qualities that make him a cornerstone of the Braves' rotation.

Since his arrival in Atlanta in a trade for Vaughn Grissom before the 2024 season, Sale has been a powerhouse. He's accumulated 10.0 fWAR over 303 1/3 innings, with a collective 59 ERA-, 59 FIP-, and 69 xFIP-. His standout 2024 season even earned him the coveted NL Cy Young Award.

With injuries affecting the Braves' pitching staff, Sale's presence is crucial. His ability to anchor the rotation provides stability and confidence, making this extension a strategic move for the team's future success.